Skip to main content
Clinical Trials/NL-OMON33051
NL-OMON33051
Not Yet Recruiting
N/A

Cognitive and motor development, nerve function, somatic growth and (pubertal) development, and (spontaneous) thyroid function in 10,5 years old Down syndrome children after thyroxine or placebo treatment until the age of 2 years. - Neurodevelopment in Down syndrome after thyroxine treatment early in life

Academisch Medisch Centrum0 sites181 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Down syndrome en Down's syndrome
Sponsor
Academisch Medisch Centrum
Enrollment
181
Status
Not Yet Recruiting
Last Updated
last year